Larry Robbins' Glenview Capital Management Bolsters Stake in Myriad Genetics Inc
On December 31, 2023, Glenview Capital Management, led by Larry Robbins (Trades, Portfolio), made a significant addition to its investment portfolio by acquiring 1,500,000 shares of Myriad Genetics Inc (NASDAQ:MYGN). The trade had a 0.65% impact on the portfolio, bringing the position to 2.29% of the portfolio and 5.97% of the company's shares.